Insmed Inc. buy Wells Fargo & Company
Start price
23.03.26
/
50%
€126.00
Target price
23.03.27
€151.55
Performance (%)
-15.11%
Price
13.08.26
€109.82
Summary
This prediction is currently active. The price of Insmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.11%. This prediction currently runs until 23.03.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 27.653% | 27.653% |
| iShares Core DAX® | 0,88 % | 5,63 % |
| iShares Nasdaq 100 | 2,39 % | 1,57 % |
| iShares Nikkei 225® | 4,27 % | 2,52 % |
| iShares S&P 500 | 1,17 % | 2,55 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its price target lowered by Wells Fargo & Company from $208.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat